Search Within

Melanoma and Immunotherapeutics Service

Formats
  1. Journal Article (955)
  2. Meeting Abstract (774)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1864)
  2. Solid Tumor Oncology Division (1864)
  3. GSK Faculty (1050)
  4. Melanoma Disease Management Team (785)
  5. Hematologic Malignancies, Division of (509)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (441)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (363)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (245)
  6. Margaret Callahan (198)

More People

Years
  1. 2025 (26)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (333)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (91)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (345)
  2. American Association for Cancer Research (275)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1864)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc)RNA-sequencing (seq)
    Meeting Abstract

    Katims, A. B.; Kuo, F.; Reisz, P.; Tracey, A.; Thomas, J.; Yip, W.; Merghoub, T.; Bochner, B. H.; Pietzak, E. J.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Associations between race/ethnicity, language, and enrollment on cancer research studies
    Journal Article

    Ezeoke, O. M.; Brooks, G.; Postow, M. A.; Baxi, S.; Kim, S. Y.; Narang, B.; Diamond, L. C.
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Colorectal cohort analysis from the intraperitoneal chemotherapy after cytoreductive surgery for peritoneal metastasis (ICARuS) clinical trial
    Meeting Abstract

    Nash, G. M.; Garcia-Aguilar, J.; Paty, P.; Gonen, M.; Foote, M. B.; Chung, S.; Mohamed, M.; Aguirre, N.; Weiser, M. R.; Rassam, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pilot study of ONCOS-102 and pembrolizumab: Remodeling of the tumor microenvironment and clinical outcomes in anti-PD-1-resistant advanced melanoma
    Journal Article

    Shoushtari, A. N.; Olszanski, A. J.; Nyakas, M.; Hornyak, T. J.; Wolchok, J. D.; Levitsky, V.; Kuryk, L.; Hansen, T. B.; Jäderberg, M.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Journal Article

    Kahn, R. M.; Ragupathi, G.; Zhou, Q. C.; Iasonos, A.; Kravetz, S.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Aghajanian, C.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients
    Journal Article

    Betof Warner, A.; Tarhini, A.; Kang, B.; Nakasato, A.; Ling, Y. L.; Shah, R.; Tang, J.; Patel, J.
    Melanoma Research (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Assessing the correlation between CD8 cell PET imaging with 89-ZR-crefmirlimab berdoxam and CD8 cell immunohistochemistry in patients with advanced cancer receiving immunotherapy
    Meeting Abstract

    Postow, M.; Mauguen, A.; Farwell, M.; Gordon, M.; Hays, D.; Wong, J.; Pal, S.; Chen, D.; Ulaner, G.; McConathy, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Signal-regulatory protein alpha (SIRPα) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save